Sildenafil improves exercise capacity in patients with cystic fibrosis: a proof-of-concept clinical trial:

Background:Exercise intolerance is a common phenotype observed in patients with cystic fibrosis (CF). Treatment with sildenafil, a phosphodiesterase type 5 (PDE5) inhibitor, has previously been sho...